Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) had its price objective increased by Wells Fargo & Company from $186.00 to $188.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s price target would indicate a potential upside of 6.49% from the company’s previous close.
Several other analysts have also recently commented on MRSH. Cantor Fitzgerald raised their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Citigroup downgraded shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price objective for the company. in a research report on Wednesday. JPMorgan Chase & Co. lifted their price objective on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Finally, Mizuho increased their target price on Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $201.69.
Check Out Our Latest Report on MRSH
Marsh & McLennan Companies Price Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its quarterly earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The firm had revenue of $7.28 billion during the quarter. The firm’s revenue was up 6.2% compared to the same quarter last year. On average, analysts forecast that Marsh & McLennan Companies will post 10.39 earnings per share for the current year.
Insider Activity
In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares of the company’s stock, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
Hedge Funds Weigh In On Marsh & McLennan Companies
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Solstein Capital LLC acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth $25,000. Asset Dedication LLC acquired a new stake in Marsh & McLennan Companies in the 1st quarter valued at about $25,000. SHP Wealth Management purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp acquired a new position in Marsh & McLennan Companies during the fourth quarter worth about $27,000. Finally, Golden State Wealth Management LLC purchased a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $27,000. 87.99% of the stock is owned by institutional investors and hedge funds.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
